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The Gram-negative bacterium Pseudomonas aeruginosa is a life-threatening
nosocomial pathogen due to its generally low susceptibility toward antibiotics.
Furthermore, many strains have acquired resistance mechanisms requiring new
antimicrobials with novel mechanisms to enhance treatment options. Proline-rich
antimicrobial peptides, such as the apidaecin analog Api137, are highly efficient
against various Enterobacteriaceae infections in mice, but less active against
P. aeruginosa in vitro. Here, we extended our recent work by optimizing lead peptides
Api755 (gu-OIORPVYOPRPRPPHPRL-OH; gu = N,N,N′,N′-tetramethylguanidino,
O = L-ornithine) and Api760 (gu-OWORPVYOPRPRPPHPRL-OH) by incorporation of
Ile-Orn- and Trp-Orn-motifs, respectively. Api795 (gu-O(IO)2RPVYOPRPRPPHPRL-OH)
and Api794 (gu-O(WO)3RPVYOPRPRPPHPRL-OH) were highly active against
P. aeruginosa with minimal inhibitory concentrations of 8–16 and 8–32 µg/mL
against Escherichia coli and Klebsiella pneumoniae. Assessed using a quartz crystal
microbalance, these peptides inserted into a membrane layer and the surface activity
increased gradually from Api137, over Api795, to Api794. This mode of action
was confirmed by transmission electron microscopy indicating some membrane
damage only at the high peptide concentrations. Api794 and Api795 were highly
stable against serum proteases (half-life times >5 h) and non-hemolytic to human
erythrocytes at peptide concentrations of 0.6 g/L. At this concentration, Api795
reduced the cell viability of HeLa cells only slightly, whereas the IC50 of Api794 was
0.23 ± 0.09 g/L. Confocal fluorescence microscopy revealed no colocalization of
5(6)-carboxyfluorescein-labeled Api794 or Api795 with the mitochondria, excluding
interactions with the mitochondrial membrane. Interestingly, Api795 was localized in
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endosomes, whereas Api794 was present in endosomes and the cytosol. This was
verified using flow cytometry showing a 50% higher uptake of Api794 in HeLa cells
compared with Api795. The uptake was reduced for both peptides by 50 and 80%,
respectively, after inhibiting endocytotic uptake with dynasore. In summary, Api794 and
Api795 were highly active against P. aeruginosa in vitro. Both peptides passed across the
bacterial membrane efficiently, most likely then disturbing the ribosome assembly, and
resulting in further intracellular damage. Api795 with its IOIO-motif, which was particularly
active and only slightly toxic in vitro, appears to represent a promising third generation
lead compound for the development of novel antibiotics against P. aeruginosa.
Keywords: antibiotic, apidaecin, cell uptake, confocal fluorescencemicroscopy, proline-rich antimicrobial peptide
(PrAMP), quartz crystal microbalance (QCM), transmission electron microscopy (TEM)
INTRODUCTION
Numerous classes of antibiotics developed and clinically
approved in the last century have rescued millions of
people from life-threatening infections. However, initial
enthusiasm that bacterial pathogens are conquered, disappeared
within two decades due to an increased antibiotic resistance.
Bacterial resistance mechanisms are very diverse and especially
pronounced in Pseudomonas aeruginosa. This opportunistic
Gram-negative non-fermenting bacterium causes severe
nosocomial infections, such as pneumonia, urinary tract
infections and bacteremia, and is intrinsically resistant for
different reasons: The low membrane permeability (Yoshimura
and Nikaido, 1982) together with efficient eﬄux systems,
such as MexAB-OprM and MexX-MexY, are responsible for
resistances against quinolones, tetracyclines, chloramphenicol,
sulfamethoxazole, trimethoprim, aminoglycosides, and some
β-lactams (Li et al., 1995; Köhler et al., 1996; Zhao et al., 1998;
Aires et al., 1999; Masuda et al., 2000). Beta-lactam antibiotics
may also fail due to an AmpC-inducible chromosomal β-
lactamase (Hancock and Speert, 2000). Furthermore, horizontal
gene transfer has enabled P. aeruginosa strains to express
aminoglycoside-modifying enzymes, whereas mutations may
alter the binding sites of peptide targets (Hancock and Speert,
2000; Vakulenko and Mobashery, 2003). Adaptive resistance
mechanisms are transiently triggered by environmental stimuli,
such as cations, biocides, polyamides, and antibiotics, and
expand the intrinsic resistance (Fernández et al., 2010, 2011).
In 2010, adaptive resistance against the last resort antibiotics
polymyxin B and colistin was reported, which is mediated
by the two-component regulatory system ParR-ParS via
activation of the arnBCADTEF operon (Fernández et al., 2010),
which finally decreases the negative net charge of the outer
membrane thereby lowering the binding efficiency of cationic
antibiotics. The arnBCADTEF operon is also activated by
low magnesium concentrations and antimicrobial peptides
(AMPs) indolicidin and human cathelicidin LL-37 (Gooderham
et al., 2008). Alternatively, P. aeruginosa can secrete the
virulence factor and proteolytic enzyme elastase (also called
pseudolysin) to degrade AMPs like LL-37 (Schmidtchen et al.,
2002).
Clearly, there is a strong medical imperative to find and
evaluate novel antibiotics, and this has led to an intensive
focus on AMPs in recent years. AMPs are expressed in
virtually all higher organisms as part of their innate immunity
(Boman, 1995). Especially promising appear proline-rich AMPs
(PrAMPs), because they can cross bacterial membranes without
lysis and act by inhibition of intracellular targets (Otvos, 2002;
Scocchi et al., 2011; Krizsan et al., 2014, 2015a,b). Insect-
derived PrAMPs are approximately 20 residues long with the
proline content typically exceeding 25%. These prolines are
often incorporated into a Pro-Arg-Pro-motif resulting in high
proteolytic stabilities (Bulet et al., 1999). They are especially
active against Enterobacteriaceae, where they pass across the
inner membrane via a transporter before inhibiting intracellular
proteins, such as chaperone DnaK and the 70S ribosome
(Kragol et al., 2001; Otvos, 2002; Mattiuzzo et al., 2007;
Krizsan et al., 2014, 2015a,b). Several studies have reported
high efficacies of native, optimized, and designed PrAMPs in
different murine mouse infection models (Noto et al., 2008;
Benincasa et al., 2010; Knappe et al., 2012). For example,
Api137 (gu-ONNRPVYIPRPRPPHPRL-OH, gu = N,N,N′,N′-
tetramethylguanidino, O = Orn = L-ornithine), an analog
of apidaecin 1b, was optimized for antibacterial activity and
proteolytic stability (Berthold et al., 2013). This PrAMP is highly
active against several threatening Gram-negative bacteria by
inhibiting the ribosome assembly (Krizsan et al., 2015b). Api137
shows a high in vivo tolerance with no acute toxic effects observed
for four intraperitoneal injections of 80 mg/kg per day, while it is
highly efficient in mouse infection models with Escherichia coli
ATCC25922 providing 100% survival rates, even at low doses of
only 0.6 mg/kg (unpublished data).
Recently, this lead-peptide was optimized to enhance
its activity against P. aeruginosa in full strength media
using a structure-activity relationship (SAR) study (Bluhm
et al., 2015). Among several interesting peptide analogs,
Api755 (gu-OIORPVYOPRPRPPHPRL-OH) and Api760 (gu-
OWORPVYOPRPRPPHPRL-OH)were particularly active. Here,
we report further N-terminal modifications by substituting the
Asn-Asn motif in Api137 by up to three Ile-Orn- and Trp-
Orn-motifs. The new PrAMPs were evaluated with respect to
minimal inhibitory concentrations (MICs) against P. aeruginosa,
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E. coli, and Klebsiella pneumoniae, activity toward bacterial
membranes assessed using quartz crystal microbalance (QCM)
and transmission electron microscopy (TEM), and in vitro
tolerance and uptake by mammalian cells investigated using
confocal laser scanning microscopy and flow cytometry.
MATERIALS AND METHODS
Materials were obtained from the following manufacturers:
Applichem GmbH (Darmstadt, Germany): Hoechst 33342
(≥98%) and Tris ultrapure (≥99.9%); Avanti Polar Lipids
(Alabaster, USA): 1,2-Dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) and 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-
glycerol) (sodium salt) (DMPG). Biosolve BV (Valkenswaard,
Netherlands): dimethylformamide (DMF, peptide synthesis
grade), dichloromethane (DCM, synthesis grade), and
piperidine (synthesis grade); Bruker Daltonics GmbH (Bremen,
Germany): α-cyano-4-hydroxycinnamic acid (CHCA); Carl
Roth (Karlsruhe, Germany): di-potassium phosphate (≥99%),
ethanol (HPLC grade), methanol (≥99%), sodium dodecyl
sulfate (SDS, ≥99.5%), trichloroacetic acid (TCA ≥99%),
and trifluoroacetic acid for peptide synthesis (≥99.9%);
Gibco (Darmstadt, Germany): phosphate buffered saline
(PBS, pH 7.4), Dulbecco’s modified Eagle’s medium/Ham’s
F-12 medium (DMEM/F-12 (1:1); Penicillin-Streptomycin
(10,000 U/mL) and fetal bovine serum (FBS, qualified, heat
inactivated, E.U.-approved, South America Origin); eBioscience
(San Diego, USA): eFluor660; Electron Microscopy Sciences
(EMS, Hatfield, USA): osmium tetroxide and uranylacetate;
Greiner Bio-One GmbH (Frickenhausen, Germany): 48-well
polystyrene (PS), 96-well polypropylene (PP) or PS, and
384-well PS microtiter plates; ibidi GmbH (Martinsried,
Germany): µ-Slide 8 well ibiTreat; Iris Biotech (Marktredwitz,
Germany): Leu-Wang resin; Life Technologies (Carlsbad, USA):
MitoTracker red CMXRos, Merck (Darmstadt, Germany):
calcium chloride (CaCl2), magnesium chloride (MgCl2),
potassium hexacyanoferrate(II) trihydrate (K4Fe(CN)6 x3H2O)
and P. aeruginosa Elastase; MultiSynTech GmbH (Witten,
Germany) or Iris Biotech (Marktredwitz, Germany): all
9-fluorenylmethoxycarbonyl- (Fmoc) protected amino acids
and N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium
hexafluorophosphate (HBTU); PAA Laboratories GmbH:
mouse serum; Phenomenex Inc. (Torrance, CA, USA): Jupiter
C18-columns [internal diameter (ID)]: 10 mm and length:
250 mm or ID: 2 mm and length: 150 mm, particle size: 5
µm, pore size: 30 nm); Polysciences (Eppelheim, Germany):
glutaraldehyde; Sigma-Aldrich GmbH (Taufkirchen, Germany
and Zwijndrecht, The Netherlands): 1,2-ethandithiole (≥98%),
acetic anhydride, 5(6)-carboxyfluorescein (Cf, ≥95%), m-cresole
(99%), thioanisole (≥99%), N,N′-diisopropylcarbodiimide
(DIC, >98% by GC), N,N-diisopropylethylamine (DIPEA),
hydrochloric acid (HCl, p. a.), dynasore hydrate, 1-hydroxy-
benzotriazole (HOBt, >98%), low-melting point agarose,
N-methylmorpholine (NMM, >95% GC), Mueller-Hinton
broth (MHB), β-nicotinamide adeninedinucleotide reduced
disodium salt hydrate (NADH), paraformaldehyde (95%),
potassium phosphate monobasic (≥99.5%), TFA (UV-grade for
HPLC), sodium cacodylate, sodium hydroxide (≥90%) sodium
pyruvate (≥99%), methylthiazolyldiphenyl-tetrazolium bromide
(MTT, ≥98%), triisopropylsilane (TIS, 98%), triton X-100, and
tryptic soy broth (TSB). Sigma-Aldrich (Castle Hill, Australia):
cholesterol and chloroform (≥99.8%).
Peptide Synthesis
Peptides were synthesized using Fmoc/tBu-strategy and in
situ DIC/HOBT activation (25-µmol scale). Side chains of
trifunctional amino acids were protected with 2,2,4,6,7-
pentamethyl-2,3-dihydrobenzofuran-5-sulfonyl for Arg,
tert-butyl for Asp, Glu, Ser, Thr, and Tyr, tert-butyloxycarbonyl
for Lys, Trp, and Orn, and trityl for Cys, His, Asn, and Gln.
N-terminal residues Ile2 and Orn1 of Api796 were coupled
manually with HBTU in the presence of DIPEA overnight.
Cf-labeled peptides were obtained by incorporating Orn1
protected at the side chain with either the 4-methyltrityl (Mtt)
(Api137) or the 1-(4,4-dimethyl-2,6-dioxocyclo-hexylidene)-
3-methylbutyl (ivDde) (Api794, Api795). The N-terminal
Fmoc-group was cleaved with piperidine and the N,N,N′,N′-
tetramethylguanidino group incorporated by incubating the
peptides with 10 equivalents of HBTU and NMM in DMF (0.5
mL). For Cf-labeling Mtt- or ivDde-groups were cleaved by
repetitive treatments with 2% TFA in DCM or 2% hydrazine
in DMF, respectively, before glycine, serine and Cf (8 eq.)
were manually coupled with HBTU (8 eq.) and DIPEA (8 eq.).
Peptides were cleaved with TFA containing a scavenger mixture
(12.5% v/v; ethandithiole, m-cresol, water, and thioanisole,
1/2/2/2 v/v/v/v) and precipitated and washed with cold diethyl
ether. Peptides were purified by RP-HPLC on a Jupiter C18-
column (ID: 10 mm) using a linear aqueous acetonitrile gradient
containing TFA (0.1% v/v) as ion pair reagent. Purities were
judged by RP-HPLC and MALDI-QqTOF-MS (Synapt G2Si MS
Waters, Eschborn, USA, Germany) (Figures S1, S2).
Antimicrobial Activities
MICs of P. aeruginosa strains DSM 1117 (ATCC 27853), DSM
3227 (ATCC 19429), and DSM 9644 were determined in a
microdilution broth assay using 50 or 100% MHB (11.5 and
23 g/L MHB, respectively) whereas MICs of E. coli DSM 1103
(ATCC 25922) and K. pneumoniae DSM 681 (ATCC 10031)
were determined in TSB (30 g/L TSB). Peptides (1 g/L in water)
were serially two-fold diluted in a 96-well microtiter plate (PS,
sterile, flat bottom) in 50 µL of the corresponding medium to
final concentrations of 512–4 µg/mL. Bacteria were grown in
nutrient broth overnight and diluted to a cell concentration of
1.5 × 107 cells/mL in the corresponding medium. Cell densities
were determined by using the McFarland standard as reference.
An aliquot (50 µL) of the cell culture was added to each
well and incubated (37◦C, 24 h). The OD595 was determined
in a SpectraMax 340PC (Molecular Devices, Sunnyvale, USA).
Additionally, MIC values were also determined for high bacteria
densities (5× 108 cells/mL) corresponding to the conditions used
for TEM, as described above.
Quartz Crystal Microbalance
Data were acquired with the Q-Sense E4 system (Q-sense,
Sweden using polished, gold-coated, AT-cut quartz sensors
with a fundamental frequency of ca. 5 MHz (Q-Sense, Västra
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Frölunda, Sweden) (Mechler et al., 2007; McCubbin et al.,
2011). Briefly, sensors were cleaned with hydrogen peroxide
(6% w/v) and aqueous ammonia (5.6% w/v) for 20 min
(70–75◦C), washed with water, and then activated with 3-
mercaptopropionic acid (1 mmol/L in isopropanol) overnight.
Liposomes consisting of DMPC and DMPG (molar ratio of 4:1)
were deposited onto the sensors, washed with “high salt” PBS
(20 mmol/L potassium phosphate, 0.1 mol/L NaCl, pH 6.9) and
then with “low salt” PBS (10 mmol/L potassium phosphate,
30 mmol/L NaCl, pH 6.9). The system was equilibrated at
19.1 ± 0.1◦C with “high salt” PBS, prior to the introduction
of peptide solutions (2; 5; 10 and 20 µmol/L, 1 mL each
in “high salt” PBS) at a flow rate of 50 µL/min over 20
min followed by an incubation, without any flow. Afterwards
the “high salt” PBS was again introduced at 300 µL/min to
determine if any surface materials could be removed from the
sensor. Changes in the sensor frequency (1f ) and dissipation
(1D) were monitored for the third, fifth, seventh, and ninth
harmonic using Q-Soft (Q-Sense) and analyzed using Origin 8
software.
Transmission Electron Microscopy (TEM)
P. aeruginosa and E. coli were incubated at bacterial densities
of 5 × 108 colony-forming units (CFU)/mL (determined on an
agar plate) with peptides at different concentrations (0.25×MIC,
MIC, 4×MIC and 512µg/mL, Table S1) for 1 h at 37◦C. Peptide-
bacteria mixtures were fixed (2% glutaraldehyde, 5 mmol/L
CaCl2, 10 mmol/L MgCl2 in 0.1 mol/L sodium cacodylate buffer,
pH 7.4) overnight at 4◦C. Cells were washed (3 × 10 min),
embedded in low-melting point agarose (2% v/v), and postfixed
(4% (w/v) osmium tetroxide, 15% (w/v) K4Fe(CN)6 in distilled
water) for 2 h at 4◦C. Samples were rinsed with distilled water
(5 × 10 min), incubated with aqueous uranylacetate (0.5% w/v)
for 1 h at 4◦C, washed with distilled water (3 × 10 min), and
embedded in Epon. The hardened blocks were sectioned (50 nm)
on a UCT ultramicrotome (Leica, Vienna, Austria), stained with
uranyl acetate and lead citrate on an AC20 system (Leica), and
visualized at a Tecnai 12 electron microscope (FEI, Eindhoven,
The Netherlands) at 80 kV.Morphological effects were quantified
on average for 25 cells per condition.
Serum Stability
Peptide solutions (1 g/L) were added to mouse serum to obtain
final concentrations of 70 mg/L peptide and incubated under
constant shaking at 37◦C. After 0, 1, 2, 3, and 6 h aliquots (95µL)
were precipitated with aqueous TCA (25µL, 15%w/v), incubated
for 10 min on ice, and centrifuged (5 min, 12,000× g, Eppendorf
mini spin centrifuge). An aliquot of the supernatant (95 µL) was
neutralized with sodium hydroxide (8 µL, 1 mol/L) and diluted
with aqueous acetonitrile solution (3% acetonitrile, 0.1% TFA;
200 µL). Peptides were quantified by the peak areas obtained
by analytical RP-HPLC on a Jupiter C18-column (ID: 2 mm)
using a linear aqueous acetonitrile gradient with 0.1% (v/v) TFA
(absorbance recorded at 214 nm). Peak areas of all time points
were normalized to the initial peak area obtained after “0 min
incubation” (=100%). Experiments were carried out as triplicates
in parallel and half-life times were calculated using GraphPad
Prism 5.0.
Elastase Assay
A stock solution of P. aeruginosa elastase (0.26 U/µL) was
prepared in Tris-HCl (5 mmol/L, pH 8.3) and stored at −80◦C.
Peptides (0.5 g/L in 5 mmol/L Tris-HCl, pH 8.3) were incubated
with elastase (0.012 U/µL) at 37◦C under constant shaking (450
rpm) for 0, 0.5, 2, 4, and 6 h. Aliquots (10.5µL) were precipitated
with a mixture of acetonitrile and ethanol (1:1 v/v) containing
0.1% TFA (21 µL), centrifuged, the supernatant transferred into
a new tube, and dried in vacuum. Samples were dissolved in
aqueous acetonitrile (3% v/v) containing TFA (0.1% v/v) and
analyzed by RP-HPLC using the conditions described above.
Half-life times were calculated using GraphPad Prism 5.0.
Hemolysis Assay
Human EDTA blood (S-Monovette R© with potassium-EDTA
Sarstedt AG, Nümbrecht, Germany) was centrifuged (3 min,
300 × g, 4◦C) and blood cells were washed three times using the
10-fold volume of cold PBS. The diluted blood cell suspension
(2% v/v in PBS, 50 µL) was mixed with a peptide solution (1.2
or 0.2 g/L in PBS, 50 µL) or triton X-100 (1%, v/v in PBS;
control) in 96-well plates (PP, V-bottom). After incubation under
constant shaking (1 h, 37◦C, 300 rpm, Eppendorf Thermomixer)
the suspension was centrifuged (3 min, 4◦C, 1000 × g) and
the OD405 of the supernatant was measured in a 384-well plate
(PS, flat bottom, Paradigmmicroplate reader, Molecular Devices,
Sunnyvale, USA). The hemolytic grade (HG) was calculated as
[(ODPeptide−ODPBS)/(ODTriton−ODPBS)]× 100%.
Cytotoxicity
Human embryonic kidney (HEK293) and HeLa cells were
cultured in Dulbecco’s modified Eagle’s/Ham’s F-12 medium
[DMEM/F-12 (1:1)] supplemented with FBS (10% v/v),
penicillin, and streptomycin (1000 units each). Primary
rat cardiomyocytes (Innoprot, Elexalde Derio, Spain) were
grown in medium supplemented with FBS (20% v/v), horse
serum (5% v/v), L-glutamine (2 mmol/L), sodium pyruvate (2
mmol/L), MEM non-essential amino acids (Gibco, 0.1 mmol/L),
penicillin, and streptomycin (1000 units each). Surfaces for
cardiomyocyte growth were coated with attachment factor first.
Cells (20,000/well) were seeded into a 96-well plate (PS, sterile,
flat bottom), incubated for 24 h (37◦C, 5% CO2), and washed
twice with PBS (100 µl/well) prior to adding colorless medium
(88 µL) and peptide solution (12 µL; 5, 2.5, 1.25, 0.75, and 0.625
g/L in PBS). Positive controls were triton X-100 (1%, v/v) and
melittin (60 mg/L) as lytic peptide, whereas PBS (12%, v/v)
served as negative control. After an incubation period of 24
h, supernatant (25 µL) was mixed with lactate dehydrogenase
(LDH) substrate (175 µL; 0.57 mmol/L sodium pyruvate, 0.24
mmol/L NADH disodium salt, 32 mmol/L potassium dihydrogen
phosphate, 66 mmol/L dipotassium phosphate) in 96-well plates
(PS, sterile, flat bottom). Absorbance was recorded at 340 nm
every 3 min for 30 min on the Paradigm microplate reader. Due
to the total release of LDH upon triton X-100 treatment, the
control contained high LDH concentrations resulting in a fast
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substrate turnover that was only linear for the first 6 min. Hence,
the differences of the absorbances recorded initially (t = 0 min)
and after 6 min (1OD) were used for all samples and normalized
to the corresponding values obtained for triton X-100 at the time
points using the equation [(1ODPeptide −1ODPBS)/(1ODTriton
−1ODPBS)]× 100%.
The MTT cell viability assay relied on the same cell culture.
Remaining medium was replaced by a mixture of fresh colorless
medium (100 µL) and MTT (10 µL; 5 g/L in PBS) and incubated
for 4 h (37◦C, 5% CO2). A solution of sodium dodecyl sulfate
(100 µL; 10%, w/v) dissolved in hydrochloric acid (10 mmol/L)
was added, incubated (16 h), and the absorbance recorded
at 590 nm relative to the reference at 650 nm (Paradigm
microplate reader). The relative cell viability was calculated by
[(ODPeptide − ODTriton)/(ODPBS − ODTriton)] × 100% and half-
maximal inhibitory concentrations (IC50) with an Excel-template
from cell biology protocols (www.sciencegateway.org/protocols/
cellbio/drug/hcic50.htm). For statistical analysis an unpaired t-
test was applied using GraphPad Prism 5.0.
Confocal Laser Scanning Microscopy
HeLa cells (50,000 in 300 µL DMEM/F-12 medium) were seeded
into µ-slides (eight wells) and incubated (23 ± 1 h) using the
same conditions as described above and washed twice with PBS
(300 µL/well).
Mitochondrial Stain
Fresh colorless medium (144 µL) containing MitoTracker Red
CMXRos (0.1 µmol/L) and Cf-labeled peptide (6 µL; 1 mmol/L
in water) was added and incubated (6 h, 37◦C). The cells were
washed three times (300 µL PBS/well), fixed with formaldehyde
(2% w/v in PBS, 150 µL, 15 min) at room temperature (RT),
and washed twice (300 µL PBS/well) before Hoechst 33342 stain
was added (2 µmol/L in PBS, 300 µL). After 30 min (RT) the
supernatant was removed and fresh PBS (300 µL) added.
Endocytosis Inhibition
Fresh colorless medium (150 µL) supplemented with either
dynasore (0.2 mmol/L) dissolved in DMSO (final concentration
of 0.2% v/v) or DMSO (0.2% v/v) as vehicle control was
added. After 45 min (37◦C) the supernatant was replaced by
fresh medium supplemented with either dynasore or DMSO
at the same concentrations (144 µL), Cf-labeled peptide added
(6 µL, 1 mmol/L in water), and incubated (30 min, 37◦C).
Cells were fixed and stained with Hoechst 33342 as described
above.
Cells were imaged on a TCS SP5 microscope (Leica
Mikrosysteme, Wetzlar, Germany) using a HCX PL APO λ
blue 63×/1.4 OIL UV lens (number 11506192) and the LAS
AF 2.6.0 software. Hoechst 33342, 5(6-)carboxyfluorescein, and
MitoTracker Red CMXRos were detected using at 405 nm
(diode laser), 488 nm (argon laser), and 561 nm (DPSS laser),
respectively.
Flow Cytometry
HeLa cells (50,000 for endocytosis inhibition and 70,000 for
uptake kinetics) suspended in DMEM/F-12 medium (300µL; see
above) were seeded into 48-well plates (PS, sterile, flat bottom)
and incubated (23 ± 1 h) using the conditions described above.
Cells were washed twice with PBS (300 µL/well) and fresh
medium was added (144 µL).
Cell Uptake
Peptide solutions (6µL; 1mmol/L inH2O)were added to achieve
a concentration of 40 µmol/L at different time points. Cells were
washed three times with PBS (300 µL/well), treated with trypsin
(75 µL; 0.05% w/v trypsin, 5 min, 37◦C), rinsed off the plate
using cold PBS (600 µL/well), and trypsin was removed by two
washing steps (400× g, 4◦C, 4 min, 600 µL PBS each). Cells were
suspended in PBS (0.1 mL) containing eFluor660 (1000× diluted
in PBS) and incubated on ice in the dark. After 30 min, cells were
washed with cold PBS twice, suspended in formaldehyde (100
µL; 2% w/v in PBS), incubated (15 min, RT), washed (200 µL
PBS), stored in FACS buffer (200µL; 3% FBS, 0.1% NaN3 in PBS)
overnight, and analyzed on a FACSCalibur (Becton Dickinson,
New Jersey, USA). Alternatively, cells were fixed directly without
prior eFluor660 staining.
Endocytosis Inhibition
Cell cultures were prepared and incubated in the presence of
dynasore, as described formicroscopy. Cells were washed, treated
with trypsin, and fixed as described above, dissolved in FACS
buffer, and analyzed the same day.
RESULTS
Antimicrobial Activity
A recent SAR study provided analogs of Api137 that were
more active against P. aeruginosa due to an increased positive
net charge and hydrophobicity, such as Api755 and Api760
that were 16 times more active in 50% MHB than Api137
(Bluhm et al., 2015). In order to increase the net charge
and the hydrophobicity, we elongated the N-terminal sequence
by repeating the Ile-Orn- and Trp-Orn-motifs two or three
times, respectively. The MIC values of the resulting analogs
Api793, Api794, Api795, and Api796 were around two-fold more
active against the tested P. aeruginosa strains than Api755 and
Api760 in 50% MHB (Table 1). In full-strength MHB, the MICs
of Api793 and Api796 were 64 µg/mL (P. aeruginosa DSM
1117) and thus two-fold lower than for Api755 and Api760,
whereas peptides Api794 and Api795 were four-fold more active
(MIC = 32 µg/mL). P. aeruginosa DSM 3227 was two-fold
more susceptible to peptides containing three repeats (Api794
and Api796) than to Api755 and Api760, whereas P. aeruginosa
DSM 9644 was two- and eight-fold more susceptible against
Api793 and Api794, respectively, than the other four analogs.
Importantly, the antimicrobial activities against E. coliDSM 1103
were only slightly reduced to MICs of 8 µg/mL (only Api794
was two-fold less active). K. pneumoniae DSM 681 was most
susceptible against Api795 (MIC = 8 µg/mL), whereas Api793
and Api796 were two-fold and Api794 even four-fold less active.
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TABLE 1 | Peptide sequences and minimal inhibitory concentrations (MICs) of Api137 and its new analogs.
Code Sequence MIC [µg/mL]
P. aeruginosa
D
S
M
1
1
1
7
D
S
M
3
2
2
7
D
S
M
9
6
4
4
D
S
M
1
1
1
7
D
S
M
3
2
2
7
D
S
M
9
6
4
4
E
.
c
o
li
A
T
C
C
2
5
9
2
2
K
.
p
n
e
u
m
o
n
ia
e
D
S
M
6
8
1
50% MHB 100% MHB TSB
Api137 guONNRPVYIPRPRPPHPRL 256 >256 256 >256 >256 >256 2 16
Api755 guOIORPVYOPRPRPPHPRL 16 64 16 128 256 128 8 8
Api760 guOWORPVYOPRPRPPHPRL 16 32 8 128 256 128 8 8
Api793 guO(WO)2RPVYOPRPRPPHPRL 16 16 8 64 256 64 8 16
Api794 guO(WO)3RPVYOPRPRPPHPRL 16 16 16 32 128 16 16 32
Api795 guO(IO)2RPVYOPRPRPPHPRL 8 16 8 32 256 128 8 8
Api796 GuO(IO)3RPVYOPRPRPPHPRL 8 16 16 64 128 128 8 16
Activities were determined against three strains of P. aeruginosa in 50% and 100% MHB and one strain of E. coli and K. pneumoniae in TSB.
Cytotoxicity
Hemolytic grades of all four optimized peptides Api793 to
Api796 were below 2%, which was at the background level. This
clearly indicates that all peptides were non-hemolytic to human
erythrocytes even at high concentrations of 0.6 g/L (Table 2).
All four new apidaecin analogs affected the cell viability of rat
cardiomyocytes (Table 2, Figure 1A). After an incubation period
of 24 h, the highest concentration tested (0.6 g/L) for Api794 and
Api795 decreased the cell viability to 64 ± 3% and to 83 ± 4%,
respectively. For all peptides, the IC50 values were much above
the tested concentration range and could thus not be calculated.
This was consistent with the LDH assay indicating that cells
did not release LDH at detectable quantities when incubated
with any apidaecin analog (Figure 1B). HEK293 cells were more
susceptible to apidaecin analogs including Api137 with a cell
viability of 83 ± 3% at the highest concentration (Figure 1C)
(Berthold et al., 2013). Cell viabilities decreased to around 60%
for Api795 and Api796 containing Ile-Orn-motifs providing IC50
values of >0.6 g/L. Api793 and Api794 containing two and three
Trp-Orn-motifs, respectively, weremore toxic with IC50 values of
0.64 ± 0.05 g/L and 0.28 ± 0.03 g/L. Consistently, Api794 added
at a concentration of 0.075 g/L released LDH already at a rate of 2
± 1% relative to triton X-100, which increased to 40 ± 4% at the
highest probed concentration, whereas Api793 induced a slight
release of LDH (8± 5%) at the highest peptide concentration. In
contrast, a LDH release was not detected for Api137, Api795, and
Api796 (Figure 1D).
In agreement with the literature (Berthold et al., 2013; Bluhm
et al., 2015), Api137 did not affect the cell viability of HeLa
cells (Figure 1E), whereas Api795 reduced the cell viability to
78 ± 14% and Api796 to 61 ± 14%. Again, Api793 and Api794
were the most cytotoxic peptides with IC50 values of 0.64 ± 0.15
g/L and 0.23 ± 0.09 g/L, respectively. The LDH assay indicated
that Api137, Api795, and Api796 did not release LDH, while
Api793 had a small effect (5 ± 3%) at a concentration of 0.6 g/L
(Figure 1F). Again, Api794 released most LDH with an EC50 of
0.56± 0.16 g/L.
QCM Studies
Based on the high activity against P. aeruginosa, Api794 and
Api795 appeared the most promising lead compounds and
thus were further evaluated for the interaction with bacterial
membranes. The QCM sensor coated with a bacterial mimetic
lipid mixture (DMPC:DMPG, molar ratio of 4:1) showed 1f
values that decreased over time when peptide Api137 inserted
(binding) to the membrane (Figure 2A, i). As the frequency
changed similarly for all four harmonics assessed in parallel
(3rd, 5th, 7th, 9th) the insertion of the peptide was most
likely trans-membrane. For Api137 the magnitude of 1f (4–
5 Hz) was independent of concentration over the range 2–
20 µmol/L. No change in dissipation (1D), a measure of
the viscoelasticity of the membrane, was observed at the
concentrations examined indicating that themembrane structure
was not affected by Api137 during the incubation period ii.
During period iii of the experiment, washing with PBS buffer
solution removed approximately half of peptide Api137 (∼2 Hz)
from the membrane layer (Figure 2A). Once again, no change
in dissipation was detected during this period. Qualitatively the
(IO)2 peptide (Api795) also showed a transmembrane insertion
into the DMPC:DMPG membrane layer; 1f = 9 Hz at 2
µmol/L and 6 Hz for 5, 10, and 20 µmol/L (Figure 2B, i). This
variation was not significant but the 2 µmol/L data appeared
to be greater due to a thicker membrane layer. The 5–20
µmol/L data showed a very slight spreading of the harmonics
as the concentration increases indicating that there was a small
change in the organization of the peptide-membrane layer during
incubation period ii. This was also reflected by a small decrease in
1D-t as the concentration of Api795 increases. This corresponds
to some membrane restructuring through incorporation of the
peptide, generating a more rigid layer. Upon introduction of the
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TABLE 2 | Hemolytic grades against human erythrocytes, cytotoxicity (IC50) against rat cardiomyocytes, HEK293 cells, and HeLa cells, and half-life times
in mouse serum determined for Api137 and the four new apidaecin analogs.
Hemolytic grade [%] IC50 on cell viability [g/L] Half-life time mouse serum (min)
0.1 g/L 0.6 g/L Rat cardiomyocytes HEK293 HeLa
Api137* 0.4 ± 0.5 1.0 ± 0.2 >0.6 >0.6 >0.6 345
Api793 1.3 ± 0.4 1.6 ± 0.5 >0.6 0.64 ± 0.05 0.64 ± 0.15 246
Api794 1.7 ± 0.2 1.9 ± 0.3 >0.6 0.28 ± 0.03 0.23 ± 0.09 311
Api795 −0.8 ± 0.4 0.0 ± 0.7 >0.6 >0.6 >0.6 354
Api796 −0.8 ± 0.2 −0.1 ± 0.8 >0.6 >0.6 >0.6 249
*Data for Api137 were already published (Berthold et al., 2013; Bluhm et al., 2015).
FIGURE 1 | Cytotoxic effects of Api137 studied for rat cardiomyocytes (A,B), HEK293 (C,D), and HeLa (E,F) cell lines. Cells were incubated with peptide
concentrations of 0.075, 0.15, 0.3, and 0.6 g/L (light gray to black) for 24 h. Cell viability was determined in an MTT assay and cell membrane permeabilization in a
LDH assay. PBS (0% LDH release and 100% cell viability, respectively) and 1% triton X100 (100% LDH release and 0% cell viability, respectively) were used as
controls. The lytic peptide melittin (0.06 g/L) served as positive control. For statistical analysis, the unpaired t-test was used. ***P ≤ 0.001; **P ≤ 0.01; *P ≤ 0.05.
PBS buffer to the Api795-loaded membrane the frequency loss
was ∼1–1.5 Hz and the dissipation change was negligible. The
QCMdata for Api794 showed themaximum1f = 6–7Hz for the
higher (9th) vs. lower (3rd) harmonics for all the concentrations
(Figure 2C, i). This data was consistent with the other peptides
in-so-far as the Api794 peptide inserted in a transmembrane
manner; however, the influence of the (WO)3-motif supported an
organization of the peptide that resulted in more surface activity.
This effect was more apparent at the highest concentration (20
µmol/L) where the harmonics monitored during the incubation
period ii spread (Figure 2C). The change in dissipation for
2–10 µmol/L also showed a differential response across the
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FIGURE 2 | QCM frequency and dissipation for Api137 (A), Api795 (B), and Api794 (C) acting on surfaces coated with DMPC:DMPG (4:1) as bacterial
membrane mimics. Shown are normalized data as 1D-t and 1f-t graphs of 3rd (gray), 5th (green), 7th (black), and 9th (red) harmonics. Peptides were loaded into a
flow cell (period i), incubated (no flow) (period ii), and PBS buffer introduced into the chamber (period iii).
four harmonics examined. This effect was greatest for the 3rd
harmonic, which reflects the lipid surface and less so, for the
9th harmonic, which probed deeper within the lipid layer.
This was consistent with the greater surface re-structuring of
the membrane by the presence of tryptophan residues in the
Api794.
Transmission Electron Microscopy
In order to determine peptide-induced morphological changes,
P. aeruginosa and E. coli were incubated with different
concentrations of Api137, Api794, and Api795 based on their
individual MIC values for providing a representative comparison
among the peptides (Table S1). Thus, images of 25–30 bacteria
were (semi) quantitatively scored for each peptide and each
concentration (Tables S2, S3).
Control cells of P. aeruginosa displayed equally distributed
DNA and ribosomes (white and black areas, respectively) and
intact but wrinkled membranes (Figure 3, Figure S3, both top
right). Upon treatment with peptides, DNA and ribosomes
relocalized. Electron dense areas containing ribosomes were
clustered close to membranes while DNA-rich lighter areas
appeared in the center of the bacteria (Figure 3, Figure
S3). Additionally, and depending on the peptide and its
concentration, up to 20 small vesicles attached outside of or
just released from the bacterial membrane were observed at
each cell. Larger effects on the pseudomonal membrane included
larger dissociated fragments and highly deformed membranes or
complete membrane ruptures. However, a complete loss of the
cytoplasmic content was not observed for any of the conditions
tested.
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FIGURE 3 | Electron microscopy images of P. aeruginosa DSM 1117 incubated with Api137 (A), Api795 (B), and Api794 (C) at concentrations
corresponding to 0.25× MIC, MIC, and 4× MIC for 1 h using cell densities of 5 × 108 CFU/mL. Black bars represent 500 nm. Morphological changes are
indicated with arrows: dissociated fragments (blue), small vesicle release (green), large vesicle release (dark green), relocalized DNA (orange), slightly clustered
ribosomes (red), and extremely clustered ribosomes (dark red).
Specifically, Api137 induced some intracellular re-localization
of DNA and ribosomes as well as vesicle formation, but
both effects did not correlate to the concentration. Effects
on the bacterial membranes or increasing amounts of
dissociated fragments were not monitored, not even at 4×
MIC (Figure 3A, Figure S3A). The evidence of morphological
changes observed for Api795 and Api794 correlated much
clearer to the peptide concentration. At sub-MIC peptide values,
only small intracellular changes were observed for both peptides
(DNA/ribosomal reorganization) while the membranes were still
intact (Figures 3B,C, Figures S3B,C). When treated with Api795
at 4× MIC, membranes ruptured in 10% of the cells, which
occurred even in 80% of the cells incubated with 512 µg/mL
(Figure 3B, Figures S3B, S5A). Api794 already caused membrane
rupture at MIC, whereas spongy-like appearances were visible at
the highest probed concentrations indicative of strong distortion
of the bacterial cell (Figure 3C, Figures S3C, S5A). Furthermore,
Api794 strongly disrupted cell membrane fragments releasing
specific dense large vesicles at the two highest concentrations
distinct from the small membrane attached vesicles observed
at low concentrations. Interestingly, the ruptures initiated by
Api795 at 512 µg/mL and Api794 at lower concentrations were
mainly observed for inner membranes indicating that peptides
might have direct effects specifically on these membranes.
Untreated E. coli cells showed a homogenous distribution
of DNA and ribosomes with only a few short dissociated
fragments in the section (Figure 4, Figure S4, both top right).
A small number of these control cells appeared to have
some cytoplasm retraction and wrinkled membranes, which is
sometimes observed during fixation of the bacteria in our hands.
Contrary to P. aeruginosa, all peptides triggered only mild effects
on the morphology of E. coli, even at high concentrations of
4×MIC. For instance, intracellular effects were limited to slight
DNA and ribosome relocalization in some cells treated with
Api137 at 0.25× MIC and MIC and in cells treated with 512
µg/mL of Api795 and Api794 (Figure 4A, Figures S4A, S5B),
while no membrane disruptions were observed in any of the
peptide-treated samples. Interestingly, incubation of bacteria
with sub-MIC of Api137 induced strong vesicle formation at
the outer membrane (Figure 4A, Figure S4A), and comparable
structures were seen for Api794 at its MIC and above (Figure 4C,
Figure S4C). Interestingly, at 4×MIC of Api794 larger vesicular,
more filled structures not attached to the bacteria anymore were
observed, while at higher concentrations of Api137 the vesicles
had disappeared, making it unclear if the two types of vesicles
have a common origin.
Proteolytic Stability
Api137 is relatively stable in mouse serum with a half-life time
of 345 min (Berthold et al., 2013). The new analogs Api794
and Api795 were equally stable with half-life times of 311 and
354 min (Table 2), respectively, indicating that both Ile-Orn-
and Trp-Orn-motifs do neither induce new proteolytic cleavage
sites nor accelerate cleavages in the C-terminal part. Besides
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FIGURE 4 | Electron microscopy images of E. coli DSM 1103 incubated with Api137 (A), Api795 (B), and Api794 (C) at concentrations corresponding to
0.25× MIC, MIC, and 4× MIC for 1 h using cell densities of 5 × 108 CFU/mL. Black bars represent 500 nm. Morphological changes are indicated with arrows:
dissociated fragments (blue), small vesicle release (green), large vesicle release (red), and relocalized DNA (orange).
serum protease stabilities important for systemic applications,
degradation by proteases secreted by bacteria as potential
resistance factors is also an important consideration for judging
the therapeutic potential of AMPs (Schmidtchen et al., 2002;
Sieprawska-Lupa et al., 2004; Mattiuzzo et al., 2014). In
agreement with the literature Pseudomonas elastase degraded
LL-37 with a half-life time of only 3 min (Schmidtchen et al.,
2002; Nomura et al., 2014) yielding three degradation products
[LL37(32-37), LL37(33-37), and LL37(1-30)], whereas Api137
was fully recovered after an incubation period of 6 h (Figure 5,
Figure S6). Api794 was slowly degraded with 79± 6% remaining
after 6 h, whereas 92 ± 4% of Api795 was detected after 30
min and for all later time points. Thus, apidaecin analogs can
overcome this elastase-dependent resistance mechanism of P.
aeruginosa.
Uptake in HeLa Cells
Reportedly, 5(6)-carboxyfluorescein-labeled Api137 does not
enter mammalian cells (Hansen et al., 2012), which was
confirmed here by incubating HeLa cells with Cf-Api137
for 30 min and studying the uptake by laser scanning
microscopy, where only very light fluorescence signals were
detected (Figure 6A, Figure S7). The fluorescence of Cf-Api794
and Cf-Api795 was located mostly in vesicles and for Cf-
Api794 additionally in the cytosol (Figure 6A, Figure S7).
Flow cytometry revealed that all three labeled peptides were
time dependently internalized (Figure 7A). Relative to the
fluorescence intensity of Cf-Api794 after 6 h, the uptake of Cf-
Api137 was only 14 and 64% for Cf-Api795. The eFluor660 stain
FIGURE 5 | Stability of Api137 (black), Api795 (blue), and Api794 (red) in
the presence of elastase. Peptides (0.5 g/L) were incubated with
P. aeruginosa elastase (12 units/mL) in Tris-HCl buffer (pH 8.3) at 37◦C and
quantified by RP-HPLC. Peptide quantities are shown relative to the initial
peak area (0 min). LL-37 (gray) was used as positive control.
for dead cells confirmed that at least 85% of peptide treated cells
were alive revealing that the peptides did not lead to augmented
cell death during the experiment (Table S4).
When endocytosis of HeLa cells was inhibited with dynasore
for 45 min before addition of the peptides, Cf-Api794 and Cf-
Api795 were not detected in vesicles by confocal laser scanning
microscopy (Figure 6B, Figure S7). However, Cf-Api794 was
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FIGURE 6 | Confocal microscopy images of HeLa cells incubated with Cf-labeled apidaecin peptides. Cells were treated without (A) or with dynasore (0.2
mmol/L; B) for 45 min prior to peptide treatment (40 µmol/L, 30 min). The cells’ nuclei were visualized with Hoechst 33324 (blue). Arrows indicate examples of areas
with endosomes (white) and stained cytosol (red). Bars refer to 20 µm.
still present in the cytosol. Flow cytometry analysis of cells
treated with dynasore and Cf-Api795 showed a histogram similar
to Cf-Api137 (Figures 7C,D) clearly indicating an unspecific
background fluorescence without endocytosis. Cells treated
with Cf-Api794 in the presence of dynasore showed a broad
distribution of fluorescence intensities ranging from background
fluorescence (overlapping with water control) for a few cells to
3000 fluorescence intensity units, which was more than 10-fold
higher than observed for the maximum of Cf-Api795. Compared
to the vehicle control, the GeoMean fluorescence dropped in
the presence of dynasore by 78% for Cf-Api795 and only by
47% for Cf-Api794 (Figure 7B). The already weak fluorescence
intensity of Cf-Api137 was diminished by 62%. The significantly
lower fluorescence uptake of Api795 indicated that the uptake
of this peptide relies mostly on endocytosis. In contrast, Api794
is additionally internalized independent of endocytosis into the
cytosol.
When HeLa cells were incubated for a long period of 6 h with
MitoTracker Red CMXRos and fluorescence-labeled peptides,
Cf-Api137, Cf-Api794, and Cf-Api795 were visible in vesicles
and Cf-Api794 additionally in the cytosol (Figure 8). Most
vesicles were asymmetrically distributed around the nucleus. In
these areas the green and red fluorescence corresponding to
peptide and the MitoTracker, respectively, seemed to be partly
overlapped (shown as yellow in the merged images, Figure 8,
right). As the colocalized fluorescence was observed for all three
partially or non-toxic peptides and appeared only in small areas
of the mitochondrial network, it was most likely an unspecific
overlap indicating that apidaecin analogs do not interact with the
mitochondrial membrane system.
DISCUSSION
During evolution, bacteria and the immune system of the
corresponding hosts have developed various strategies to
overcome each other. While pathogenic bacteria have developed
strategies to circumvent hosts’ immune systems, humans
invented a number of different antibiotics during the last century
to treat bacterial infections. However, bacteria have caught up
in recent decades and are now capable of overcoming antibiotic
therapies and thus represent a major health threat especially in
immunocompromised persons. The lack of therapeutic options
and the low number of antibiotics in clinical phases demand
new substances relying on novel mechanisms and targets. In
particular, antibiotics against P. aeruginosa are urgently needed
owing to its versatile resistance mechanisms.
PrAMPs enter bacteria by different mechanisms and inhibit
at least the bacterial ribosome and chaperone DnaK, i.e. protein
translation and protein folding. The large contact area between
a PrAMP and the targeted protein together with their efficacy
as part of innate immunity in insects (and mammals) proven
for several millions of years indicate a very low probability that
bacteria can develop efficient resistances against them.
Api137 and the recently developed derivatives Api755 and
Api760 are all active against P. aeruginosa in vitro, but only
for low nutrient conditions. This clearly indicates that apidaecin
analogs are active and thus structural changes could further
improve the activity under high salt and nutrient conditions.
It must be stressed that MIC values are determined under
standardized but artificial conditions providing ideal growth
conditions for bacteria lacking any other substances interfering
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FIGURE 7 | Uptake of Cf-labeled Api137 (black), Api795 (blue), and Api794 (red) in HeLa cells determined by flow cytometry. (A) HeLa cells were
incubated for the indicated times with Api137, Api795, or Api794 (40 µmol/L). (B) HeLa cells were treated for 45 min without (filled bars) or with dynasore (0.2 mmol/L,
striped bars) before they were treated with a peptide (40 µmol/L) for 30 min. Cells not incubated with a peptide were used as controls (gray in histograms) without (C)
or with dynasore (D).
with bacterial growth besides the tested compound. In contrast,
a host (i.e. patient) does not provide an ideal environment
for pathogens and uses a combination of different measures to
suppress bacterial growth and finally to kill the pathogens, i.e.
synergistic strategies that include AMPs indicating that AMPs
might be more active in vivo than generally assumed from their
MIC values.
In continuation of a previous study (Bluhm et al., 2015),
we could increase the activity of apidaecins by elongating the
sequences with two-residuemotifs containing a basic (Orn) and a
hydrophobic amino acid (Trp or Ile) at the N-terminus. Themost
promising new analogs Api794 and Api795 were up to eight-
fold more active than Api755 and Api760 against P. aeruginosa
even in undiluted MHB, which has not been reported for
apidaecin analogs or other short, insect-derived PrAMPs. The
basic residues increase the positive net charge of the peptide
and most likely allow stronger electrostatic interactions with the
negatively charged bacterial surface. The hydrophobic residues,
especially Trp, support membrane penetration in general (de
Planque et al., 2003; Rekdal et al., 2012) and maybe in particular
that of the innermembrane of P. aeruginosa that lacks transporter
SbmA required for active transport in Gram-negative bacteria
(Mattiuzzo et al., 2007; Krizsan et al., 2015a). On the contrary, the
slight activity loss observed for both E. coli and K. pneumoniae
might be explained by a less efficient transport by SbmA due
to the longer N-terminal sequence or the hydrophobic and
basic residues, although the binding site of PrAMPs to SbmA
is unknown. The presumably more efficient interaction with
bacterial membranes was supported byQCMdata for Api794 and
Api795 that both showed a transmembrane insertion similar to
Api137, but triggered some additional membrane restructuring.
Api795 insertion generated a thicker membrane and a more
rigid layer. The effect on the membrane was even stronger for
Api794 that clearly restructured the surface in addition to its
transmembrane insertion.
Electron microscopy studies on bacterial cells showed
different morphologic changes induced by Api137, Api794,
and Api795 highlighting again that Trp and Ile affect or alter
the mechanism of bacterial killing. Although, TEM shows
morphological changes that might be related to the mode of
action of an antibiotic or represent only later (secondary) effects
of starving or dying cells, it still allows deducing important
observations that can support or partially disprove mechanistic
studies.
Importantly and in agreement with QCM, the peptides did not
lyse membranes at their MIC. Even at the highest concentration
(4× MIC) membranes of E. coli and P. aeruginosa were only
perturbed and membranous parts were released. However, no
leakage of cytosolic material was observed, contrary to reports
on for example temporin L and human HE2 peptide (Mangoni
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FIGURE 8 | Localization of the peptides in HeLa cells determined by confocal microscopy. Cells were incubated with the indicated peptide (40 µmol/L) and
MitoTracker Red CMXRos (0.1 µmol/L) for 6 h. Bars refer to 20 µm. Arrows mark the slight background fluorescence of the mitochondrial stain and the high
fluorescence of the Cf-labeled peptide, which overlap (unspecific colocalization).
et al., 2004; Yenugu et al., 2004). This strongly suggests that a
pure lytic mechanism, where peptides solely act on the bacterial
membranes, appears unlikely.
An interesting characteristic was the formation of small
vesicles or protrusions at the outer membrane of P. aeruginosa
(sub-MIC Api794) and E. coli (sub-MIC Api137 and MIC
Api 794). Morphologically comparable vesicle formation was
described for E. coli treated with Gramicidin S, a lytic peptide
that targets exclusively the bacterial membrane (Hartmann et al.,
2010). However, other non-proteinaceous toxic compounds,
such as alkanols, also induce vesicle release (Baumgarten et al.,
2012), which is considered a general stress response in Gram-
negative bacteria (McBroom and Kuehn, 2007). Overexpression
of (misfolded) proteins in the periplasmic space for example,
triggered similar bacterial vesicle formations. The vesicles
contained outer membrane and periplasmic components and
thus might remove toxic compounds from cells. It is easily
envisioned that Gram-negative bacteria try similarly to remove
membrane interacting peptides, even if the membrane is not the
final target of these peptides.
The observed relocalization of ribosomes and DNA is
comparable to the effect observed in a recent study of pleurocidin
and to a lower extent magainin II on E. coli (Kozlowska et al.,
2014). At concentrations below theirMIC a nuclear condensation
is described for both peptides, morphologically similar to
our observations for apidaecin analogs. While pleurocidin
was thought to be a pore-forming peptide with the cytosolic
membrane as primary target (Yoshida et al., 2001), other studies
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have shown that it is actually translocated over the membrane
and interferes with several macromolecular processes, including
protein and RNA synthesis (Patrzykat et al., 2002). Since
intracellular killing is a well described mode of action for natural
PrAMPs including apidaecin analogs (Otvos, 2002; Scocchi
et al., 2011; Krizsan et al., 2014, 2015b), it would be tempting
to correlate the observed intracellular morphological changes
to intracellular activity of AMPs, such as apidaecin analogs
and pleurocidin. However, this requires a comparative study
involving more peptides with known antibacterial mechanisms
to validate this correlation.
Overall, the current TEM results confirmed our previous
studies that Api795 and Api794 are most active in antibacterial
killing against P. aeruginosa, but are less efficient against E. coli.
For therapeutic applications, however, the activity loss against
E. coli can be tolerated, as the dose will be determined by the least
susceptible pathogen, which is at least in vitro still P. aeruginosa.
The stronger effects on the membrane may explain the lower
MICs of both Api794 and Api795, but they are unfortunately
not limited to prokaryotic membranes and increased also
adverse effects of Api794 on mammalian cell cultures. In this
respect, Api795 containing Ile instead of Trp residues appears
to act by favorably balanced membrane effects that increase
the activity against P. aeruginosa without initiating adverse
effects on mammalian cell lines, as indicated by cell viability
and LDH release. The lower tolerance of Api794 compared to
Api795 was supported by flow cytometry and laser scanning
microscopy indicating different uptake mechanisms of the
fluorescence-labeled derivatives in mammalian cells. Cf-Api795
entered HeLa cells in relatively large quantities by endocytosis,
but still 30% less efficient than Cf-Api794. After inhibition of
endocytosis, Cf-Api794 remained localized in the cytoplasm.
This supports the hypothesis that neither Api794 nor Api795
lead to membrane permeabilization, which was additionally
confirmed by the lack of LDH release in cardiomyocytes. The
observed endocytosis and the colocalization of Cf-Api794 or
-Api795 containing vesicles did most likely not affect cell
viability.
CONCLUSION
PrAMPs including Api137 have been successfully evaluated in
different murine Enterobacteriaceae infections models giving
reasonable hope that they are highly active and well tolerated
providing a large therapeutic window. Here, we could develop
new analogs with much more activity against P. aeruginosa
under full medium conditions. Among the new derivatives
Api795 appears to be the most promising, as it is highly
active against E. coli, K. pneumoniae, and P. aeruginosa, non-
hemolytic, and only slightly toxic against mammalian cells
even at high concentrations. Mechanistically, Api795 shows a
transmembrane insertion into bacterial mimic membranes and
initiates a structural change leading to a thicker and more
rigid membrane layer. The TEM result demonstrated that all
three peptides, despite their high sequence homology, have very
different effects on the morphology of bacteria, and that these
observable changes are very different for P. aeruginosa and E. coli.
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